Back to Search Start Over

Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats

Authors :
Mehdi Ghasemi
Amir Reza Hajrasouliha
Taha Gholipour
Ahmad Reza Dehpour
Hamed Shafaroodi
Maliheh Nobakht
Hamed Sadeghipour
Kevin Moore
Sina Tavakoli
Behtash Ghazi Nezami
Ali R. Mani
Source :
British Journal of Pharmacology. 151:591-601
Publication Year :
2007
Publisher :
Wiley, 2007.

Abstract

Background and purpose: Relaxation of corpus cavernosum, which is mediated by nitric oxide (NO) released from non-adrenergic non-cholinergic (NANC) neurotransmission, is critical for inducing penile erection and can be affected by many pathophysiological conditions. However, the peripheral effect of liver cirrhosis on erectile function is as yet unknown. The aim of the present study was to investigate the effect of biliary cirrhosis on NANC-mediated relaxation of rat corpus cavernosum and the possible roles of endocannabinoid and nitric oxide systems in this model. Experimental approach: Cirrhosis was induced by bile duct ligation. Controls underwent sham operation. Four weeks later, strips of corpus cavernosum were mounted in a standard organ bath and NANC-mediated relaxations were obtained by applying electrical field stimulation. Key results: The NANC-mediated relaxation was enhanced in corporal strips from cirrhotic animals. Anandamide potentiated the relaxations in both groups. Either AM251 (CB1 antagonist) or capsazepine (vanilloid VR1 antagonist), but not AM630 (CB2 antagonist), prevented the enhanced relaxations of cirrhotic strips. Either the non-selective NOS inhibitor L-NAME or the selective neuronal NOS inhibitor L-NPA inhibited relaxations in both groups, but cirrhotic groups were more resistant to the inhibitory effects of these agents. Relaxations to sodium nitroprusside (NO donor) were similar in tissues from the two groups. Conclusions and implications: Cirrhosis potentiates the neurogenic relaxation of rat corpus cavernosum probably via the NO pathway and involving cannabinoid CB1 and vanilloid VR1 receptors. British Journal of Pharmacology (2007) 151, 591–601; doi:10.1038/sj.bjp.0707279

Details

ISSN :
00071188
Volume :
151
Database :
OpenAIRE
Journal :
British Journal of Pharmacology
Accession number :
edsair.doi...........0eb6eacfb786309cbefe7f042475a24c